Cargando…

Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes

BACKGROUND: Metformin has been used for the treatment of type 2 diabetes by suppressing hepatic gluconeogenesis. It has been shown that the subclinical inflammatory responses play important roles in the pathogenesis of type 2 diabetes. In the present study, we determined the effects of metformin on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei, Liu, Xiaojie, Ye, Shandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122147/ https://www.ncbi.nlm.nih.gov/pubmed/27904436 http://dx.doi.org/10.1186/s12950-016-0142-3

Ejemplares similares

Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
por: Zhai, Limin, et al.
Publicado: (2015)

Application of urine C-peptide creatinine ratio in type 2 diabetic patients with different levels of renal function
por: Zhou, Wan, et al.
Publicado: (2022)

Metformin Ameliorates Epithelial–Mesenchymal Transition of Renal Tubular Epithelial Cells in Diabetes by Increasing Vitamin D Receptor Expression
por: Wen, Wenjie, et al.
Publicado: (2022)

Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium
por: Li, Yue, et al.
Publicado: (2022)

Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes
por: Huang, Bin, et al.
Publicado: (2018)

Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients
por: Liu, Xiaojie, et al.
Publicado: (2017)

Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb
por: Naicker, Nikita, et al.
Publicado: (2023)

Clinical Application of Metformin Use in Anhui Province, China: A Cross-Sectional Study
por: Chen, Li, et al.
Publicado: (2023)

The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
por: Zhang, Deyuan, et al.
Publicado: (2019)

Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
por: Cameron, Amy R., et al.
Publicado: (2016)

The effects of metformin in type 1 diabetes mellitus
por: Beysel, Selvihan, et al.
Publicado: (2018)

Risk Factors for Sarcopenia in the Elderly with Type 2 Diabetes Mellitus and the Effect of Metformin
por: Chen, Fenqin, et al.
Publicado: (2020)

Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients
por: Huang, Bin, et al.
Publicado: (2020)

Effects of metformin on endothelial function in type 2 diabetes
por: WU, SONGLIN, et al.
Publicado: (2014)

Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers
por: Abdulmalek, Shaymaa A., et al.
Publicado: (2019)

Short-term insulin intensive therapy decreases MCP-1 and NF-κB expression of peripheral blood monocyte and the serum MCP-1 concentration in newlydiagnosed type 2 diabetics
por: Lin, Yang, et al.
Publicado: (2018)

Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers
por: Wang, Yan, et al.
Publicado: (2023)

Effects of Metformin on the Cerebral Metabolic Changes in Type 2 Diabetic Patients
por: Huang, Yung-Cheng, et al.
Publicado: (2014)

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Metformin and Type 2 Diabetes Prevention
por: Aroda, Vanita R., et al.
Publicado: (2018)

Effects of sildenafil, metformin, and simvastatin on ADH‐independent urine concentration in healthy volunteers
por: Bech, Anneke P., et al.
Publicado: (2018)

The anti-diabetic effects of metformin are mediated by regulating long non-coding RNA
por: Chang, Wenguang, et al.
Publicado: (2023)

Effects of metformin on blood glucose levels and bodyweight mediated through intestinal effects
por: Harada, Norio
Publicado: (2020)

Metformin and the Development of Asthma in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Alterations in pro- and anti-inflammatory mediators are involved in microvascular dysfunction in postmenopausal women with type 2 diabetes mellitus
por: Jarrete, A.P., et al.
Publicado: (2022)

Effect of metformin on the epigenetic age of peripheral blood in patients with diabetes mellitus
por: Li, Man, et al.
Publicado: (2022)

Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention
por: Dalli, Jesmond, et al.
Publicado: (2023)

Pro-Inflammatory Mediation of Myoblast Proliferation
por: Otis, Jeffrey S., et al.
Publicado: (2014)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
por: Jeon, Hyun Jeong, et al.
Publicado: (2011)

Urine metabolome profiling of immune-mediated inflammatory diseases
por: Alonso, Arnald, et al.
Publicado: (2016)

Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus
por: Ito, Hiroyuki, et al.
Publicado: (2010)

Effects of Metformin on COVID-19 Patients with Type 2 Diabetes: A Retrospective Study
por: Guo, Ziyu, et al.
Publicado: (2023)

Chlorogenic acid attenuates pro-inflammatory response in the blood of streptozotocin-induced diabetic rats
por: Lee, Youngchan, et al.
Publicado: (2022)

Effects of Metformin on Renal Function, Cardiac Function, and Inflammatory Response in Diabetic Nephropathy and Its Protective Mechanism
por: Zhang, Zhiping, et al.
Publicado: (2022)

Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients
por: Siavash, Mansour, et al.
Publicado: (2017)

Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes
por: Bletsa, Evdoxia, et al.
Publicado: (2021)

Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity
por: Pirola, Luciano, et al.
Publicado: (2017)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

NLRP3 Blockade Suppresses Pro-Inflammatory and Pro-Angiogenic Cytokine Secretion in Diabetic Retinopathy
por: Chai, Guangrui, et al.
Publicado: (2020)

Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
por: Tan, Jixue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mia1j21h3rnhtbbmma0fc88h9j